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Abstract
Objective
Transfemoral Transcatheter Aortic Valve Implantation (TAVI) has become a standard ther-
apy for patients with aortic valve stenosis. Fluoroscopic imaging is essential for TAVI with
the anesthesiologist’s workplace close to patient’s head side. While the use of lead-caps
has been shown to be useful for interventional cardiologists, data are lacking for
anesthesiologists.
Methods
A protective cap with a 0.35 lead-equivalent was worn on 15 working days by one anesthesi-
ologist. Six detectors (three outside, three inside) were analyzed to determine the reduction
of radiation. Literature search was conducted between April and October 2018.
Results
In the observational period, 32 TAVI procedures were conducted. A maximum radiation
dose of 0.55 mSv was detected by the dosimeters at the outside of the cap. The dosimeters
inside the cap, in contrast, displayed a constant radiation dose of 0.08 mSv.
Conclusion
The anesthesiologist’s head is exposed to significant radiation during TAVI and it can be
protected by wearing a lead-cap.
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Introduction
To date about 350.000 transfemoral Transcatheter Aortic Valve Implantations (TAVI) have
been performed [1] with more than 13.000 in Germany in 2015 alone [2]. As periprocedural
fluoroscopic imaging is essential, this procedure is done in cardiologic catheterization labora-
tories (CathLabs) [3] or specially designed Hybrid-ORs. As several steps of the procedure, may
be painful to the patient or haemodynamically impairing, anesthesia managed care is manda-
tory for these patients. Thereby, the anesthesiologist’s workplace is close to the patient’s head
side. Periprocedural pain and unrest, or cases of emergency may demand a close contact of the
anesthesiologist to the patient. Furthermore, the X-ray protection, attached to the CathLab-
table, is often deficient at the head-side and a head-sided position of the C-arm may further
impede stationary X-ray protection. In recent years, radiation protection has become an
important topic for the interventional cardiologists [4] and reports of an increased incidence
of left sided brain tumors have been published [5, 6]. It has been shown that the use of lead
caps and glasses could reduce the radiation exposure of the brain in this group [7–9]. Further
data suggest that the occupational radiation exposure of the medical staff during TAVI is
highly dependent on the access site used (e.g. transapical vs. transfemoral), protection shields,
angulation of the C-arm and beam projection [10–13]. Such data is lacking for the anesthesiol-
ogist positioned at the head-side of the patient during TAVI. Therefore, this study was
designed as a pilot and it was hypothesized that, despite the presence of a protective shield, the
head of the anesthesiologist is exposed to radiation during TAVI procedures. Furthermore, it
was investigated whether the use of a lead cap could reduce the radiation exposure of the head.
Methods
This trial was a single-center observational pilot-study performed at the Institut fu¨r Ana¨sthe-
siologie, Deutsches Herzzentrum Mu¨nchen, a university-hospital specialized in cardiovascular
diseases, between February and March 2016. The decision for TAVI and the type of transcath-
eter valve was at the discretion of the institution´s heart team. All cases were conducted in the
same catheterization laboratory using a Philips ALLURA XPER FD 10 X-ray system (Philips
Medical Systems Nederland B.V., Best, Nederlands). Informed consent and ethical approval
was waived by the ethical committee of the Technische Universita¨t Mu¨nchen, as the measure-
ments were done during routine procedures.
Endpoints
The reduction of the radiation exposure at the head of the attending anesthesiologist by the
use of a lead head cap was chosen as primary endpoint.
As a secondary endpoint, the exposure of the anesthesiologist´s head to radiation during
these procedures was assessed. “Exposure” was defined as the maximum radiation to which
the head would have been exposed, if no lead cap would have been worn.
A personalized cap consisting of Novalite (Mavig, Munich Germany)–a lead composite mate-
rial with a 0.35 mm lead equivalent–was used. To ensure comparable conditions, i.e. reproducibil-
ity of the results, the same cardiac anesthesiologist utilized the cap over a period of 15 work-days
performing TAVI procedures. Six detectors—three at the outside of the cap and three at the inside
(left side, right side and in the center of the forehead)—were analyzed, as shown in Fig 1.
Anesthesiologist’s standard radiation protection
The anesthesiologist’s personal protection consisted of a personalized lead coat (including
upper arm cover), radiation protection glasses and thyroid protection. In accordance to
Periprocedural radiation protection of the anaesthesiologist´s head during TAVI
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Fig 1. Position of the detectors outside (grey) and inside (blue) the cap.
https://doi.org/10.1371/journal.pone.0210872.g001
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German Federal Regulations, a personal dosimeter was worn at chest height underneath the
protective coat. The position of the anesthesia machine and monitoring, as well as the position
of the protection shield is shown in Fig 2. The top level of the lead shield was at 145 cm, while
the anesthesiologist’s height was 182 cm, therefore the head of the anesthesiologist is actually
beyond the mobile radiation shield.
As imaging modes, fluoroscopy and cine-angiography were used during the procedure. A
low-dose program and commonly applied measures for radiation protection as focusing on
the area of interest and minimizing the distance between patient and flat-panel detector were
used [14]. Demographic data of all patients were recorded and the operative risk was assessed
by the EuroSCORE II [15].
Procedure time, radiation time and dose area product (DAP) data were collected for each
patient. DAP was used as a surrogate parameter for the total amount of radiation energy and
therefore also as a relative indicator for the scatter dose the anesthesiologist is exposed to.
Procedures were conducted in general anesthesia or conscious sedation based on the
patient´s comorbidities. Both anesthesia techniques have been described in detail before [16].
Fig 2. Room setup in the CathLab.
https://doi.org/10.1371/journal.pone.0210872.g002
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Measurement
Due to the spatial constraints inside the cap small detectors were required for all measure-
ments. At the Individual Monitoring Service of the Helmholtz Zentrum Mu¨nchen (HMGU)
different dosimeters are used for the measurement of the operational radiation protection
quantities Hp(10), Hp(3) and Hp(0.07) which provide conservative approximations for the
effective dose, eye lens dose and skin dose, respectively [17–19]. All dosimeters consist of a pas-
sive detector and a dosimeter enclosure or holder. Due to the limited space inside the lead cap
these enclosures could not be used in the experiment. The measurements were performed with
LiF thermoluminescence detectors (specifically LiF:Mg,Cu,P material, i.e. MCP-N material),
which are also utilized in extremity dosimeters like finger ring dosimeters. These detectors
were adequate for the special requirements regarding detector size and high sensitivity.
It is imperative to carefully address the issues evaluating detector signals that may be biased
by the omission of the dosimeter enclosures and the nonstandard placement attached to a lead
cap. The calibration of a dosimeter as used in the automated analysis systems at the HMGU
assumes correct placement of the dosimeter on a dedicated position on the body and considers
backscattered radiation from the body as well as radiative processes inside the dosimeter enclo-
sure such as shielding of low energy radiation and signal build up with higher photon energies.
The use of the lead cap itself modifies the radiation environment by causing different backscat-
ter for the detectors on the outside and hardening of the energy spectrum propagating to the
inside of the cap. Therefore the result of such a dose measurement cannot be interpreted as a
correct value for Hp(3) or Hp(0.07) in the strict metrological sense. However, the measure-
ments can still be used to reliably estimate the effectiveness of the shielding of the cap by calcu-
lating the relative signal between the detectors outside and inside of the cap and by estimating
the uncertainty of this relative measurement due to the modified photon spectrum and differ-
ences in backscatter.
Data evaluation
The cumulative radiation dose outside and inside the lead cap was measured and the ratio
inside to outside was calculated.
Results
During the observational period a total of 32 transfemoral TAVI procedures was conducted in
the cardiologic CathLab within 15 working days. Patient´s baseline and procedural data are
shown in Table 1.
All procedures were conducted without procedural or anesthesiologic complications. No
unplanned conversions to general anesthesia or major vascular injuries were registered.
The right outside dosimeter was discovered defect after measurements and therefore
excluded from analysis. As shown in Fig 3 the highest radiation dose was detected on the left
outside of the cap. Inside, there were comparable measurements at all three positions (left,
right, center). Compared to the outside measurements, the radiation dose inside the cap was
reduced as shown in Table 2.
Discussion
Despite the presence of a radiation protection shield, the anesthesiologist´s head was exposed
to radiation. This is due to the fact that the top height of the protective shield was at 145 cm
while the anesthesiologist was 182 cm in height Furthermore, it could be shown for the first
time in this real-life setting that the use of a particular protective cap facilitates a significant
Periprocedural radiation protection of the anaesthesiologist´s head during TAVI
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reduction of radiation, the acting anesthesiologist may be exposed to. Different other radiation
protection caps are available, partially also covering the oral mucosa and parotis glands. All
clinically evaluated models have shown the ability to reduce the radiation exposure signifi-
cantly between 62% and 90% [7, 8, 20, 21] in interventional cardiologists. Our measurements
showed a reduction of 83–85%. Therefore, the protective potential for the anesthesiologist
appears to be comparable with those for interventional cardiologists.
For many decades the brain, as a highly differentiated organ, has been considered to be
radio-resistant according to the “Law of Bergoine´ and Tribondeau” [22]. Newer research is
contradictionary to this point of view [23] and an increasing number of interventional cardiol-
ogists with left sided brain tumors seem to support the thesis of a causal relationship [6]. Vas-
cular and neurocognitive effects of radiation exposure have also been described [23, 24], but
the occupational significance is still unclear at the moment. The head´s radiation exposure has
shown to be related to the position of the physician with a focus on the left side [25]. As it can
be expected from the cardiologist’s area of work (Fig 2), radiation protective caps have been
proposed to be useful in addition to lead-glass shields [20, 25] and protective glasses [26]. Radi-
ation exposure of the anesthesiologist working at the head of the patient is dependent on dif-
ferent variable factors like the angulation of the C-Arm, the dosis-area-product, volume-
dependent scatter radiation and dose acquisition setting [27]. As several parts of the body (e.g.
the face, lower legs, arms) are still uncovered, a multimodal approach to reduce the radiation
exposure [14] is necessary. This includes the limit of radiation usage, decreased cine use, a
detector positioned close to the patient, a decreased frame rate, software magnification and
real-time dose monitoring [27–29]. Besides these techniques personalized (and fitting) radia-
tion protection equipment (apron, thyroid shield, glasses) represent the current state of the art
and have shown to reduce the exposition of the covered areas significantly [12]. Currently,
only a dosimeter (worn at the chest below the lead coat) is mandatory in Germany.
For all heart valves, interventional procedures for the treatment of acquired structural heart
disease are now available with increasing numbers. Anesthesia care for a considerable number
of these patients with a multitude of comorbidities is mandatory. As a consequence, working
in radiation environment like the CathLab will become more and more for anesthesiologists.
Although radiation dosage has decreased by implementation of new technologies [30] and
procedural experience [31] worldwide, the anesthesiologist’s exposure to radiation is generally
considered to be higher in TAVI than in other interventional procedures [12, 32]. Newer pro-
tection systems for interventional cardiologists [12] are not suitable for anesthesiologists as
Table 1. Patient´s characteristics.
Patient and procedural characteristics
Male patients (n = ) 20/32 (63%)
Age (years) 80 (75.5–84)
Body Mass Index 22.4 (20.3–24.9)
EuroSCORE II (%) 3.41 (2.28–6.23)
Balloon-expanding valve (n = ) 24 (75%)
General anesthesia (n = ) 16 (50%)
Operation time (Min) 63 (50–75)
Radiation time (Min) 11.4 (9.5–14.9)
Dose Area Product (DAP) (μGym2) 752 (382–1729)
Quantitative data are given in absolute numbers and percentage. Continuous data are given as Median (Interquartile
Range)
https://doi.org/10.1371/journal.pone.0210872.t001
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Fig 3. Radiation measurement inside and outside the cap in mSv Hp(3) (relative uncertainty ~35%, grey–outside; blue - inside): The relative
uncertainty is defined as the expanded uncertainty (k = 2) divided by the measured dose value.
https://doi.org/10.1371/journal.pone.0210872.g003
Periprocedural radiation protection of the anaesthesiologist´s head during TAVI
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they are designed for a static position and not for variable working positions. A solid shield
may protect the anesthesiologist during the routine uneventful procedure. With 145 cm of
height and 81cm width, the lead shield was lower than the head of the anesthesiologist. With a
greater shield height, the access to the patient´s head would be impaired. Same is true for a
hanging protective shield. Such a shield might protect the head of the anesthesiologist during a
static position, but such a broad shield impairs the access to the patient’s head or the position-
ing of the C-Arm from the head side.
But in the presence of severe adverse events, demanding a mask ventilation or emergency
induction of general anesthesia, this protection shield has to be removed. Despite a ten-year
experience, severe adverse events still occur [33] in a considerable number of patients. A recent
analysis of transfemoral TAVI procedures revealed a rate of conversion from sedation to gen-
eral anesthesia in nearly 6%. Most of these conversions were due to procedural complications,
followed by the need for general anesthesia due to patient´s pain or discomfort. While for the
latter, the procedure–and fluoroscopy–can be interrupted, this might not be possible during
procedure related complications. Aortic annular rupture, pericardial effusion or hemody-
namic compromising aortic regurgitation require an immediate diagnosis and therapy. This
must usually be done under fluoroscopy, with the anesthesiologist´s head close to the radiation
device without protection. Therefore, it can be assumed that the exposition to radiation is
markedly increased in these situations.
In 32 uneventful TAVI-procedures, a maximum outside radiation of 0.55±0.2 mSv was
detected which translates into ~0.69±0.23 mSv Hp(3) with a backscatter correction applied to
account for the presence of the lead cap. The exposure was highest at the left frontal side. This is
caused by the working position of the anesthesiologist. In our setting, the anesthesia-equipment
and monitoring are positioned at the right head side of the patient. As a consequence of this set-
ting, the anesthesiologist has to work with the left frontal head side towards the radiation.
Limitations
The data obtained in this trial apply only for this specific equipment and setting and might not
be generally applied. One limitation of this study is that the measured dose values in terms of
Hp(3) exhibit somewhat large uncertainties due to the use of non-enclosed detectors and their
placement inside and outside the lead cap. The uncertainties of the measurements were esti-
mated by means of data from the uncertainty analysis of the HMGU extremity dosimeters [34]
and by means of additional calibration measurements with the detectors and the lead cap on
the ISO cylinder phantom [35] (head phantom) at the calibration facilities of the HMGU. All
uncertainties in the following are given as expanded uncertainties [36] with a coverage factor
of k = 2, i.e the 95% confidentiality level. The largest dose value outside the lead cap was 0.55
±0.2 mSv, with the dominating uncertainty contributions arising from the energy response of
Table 2. Radiation measurement outside and inside the cap in mSv Hp(3).
Detector position Value outside Value inside Relation to the corresponding outside position Relation to the point of highest radiation exposure
Left 0.55 mSv Hp(3) 0.08 mSv Hp(3) 15% Outside: reference
Inside: 15%
Middle 0.48 mSv Hp(3) 0.08 mSv Hp(3) 17% Outside: 87%
Inside: 15%
Right NA 0.08 mSv Hp(3) NA Outside: NA
Inside: 15%
Therefore, the anesthesiologist´s head would have been exposed to a maximum of 0.55 mSv, if no lead cap would have been worn.
https://doi.org/10.1371/journal.pone.0210872.t002
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the detector and statistical uncertainty. However, in the calibration measurements with the
lead cap and a head phantom it was shown, that the presence of the lead cap shields the detec-
tor from backscattered radiation from the head phantom, therefore the actual value of the eye
lens dose for a person not wearing a lead cap would be about 15%-25% higher depending on
the radiation quality. The measured values inside the lead cap are in the order of 0.08±0.03
mSv. In this case the detector is used near the detection limit, which increases the uncertainties
mostly due to background subtraction, however this effect could be alleviated by means of ded-
icated background dosimeters. Even though the measurement uncertainties are pronounced at
these small dose values, the relative measurement between the outside and inside levels, i.e. the
determined decrease of 85% exhibits a comparatively smaller uncertainty of approximately
11% due to the laws of error propagation. Therefore, the conclusion of the effectiveness of the
shielding capability of the lead cap is valid.
Currently, about 650 transfemoral TAVI procedures per year are performed in our institu-
tion. Considering that this number increases and that the course of about 9% [37] is not
uneventful and accompanied by a higher radiation exposure, it would be prudent for anesthe-
siologist to wear a lead cap to complete his personal protective equipment.
Conclusion
In this pilot study, we hypotized that the head of the anesthesiologist is exposed to radiation
during TAVI. Furthermore, we evaluated the use of a lead cap to reduce the radiation expo-
sure. In 32 uneventful TAVI procedures, the head was exposed to significant radiation. This
primary due to the fact, that the protective shield was lower than the head of the anesthesiolo-
gist during routine care. As the anesthesia equipment and monitoring was placed on the right
head side of the patient, the radiation exposure of the anesthesiologist´s head was highest on
the left side. By wearing the lead cap during these procedures, a reduction of the heads radia-
tion exposure of about 85% was achieved. Despite these findings, structural radiation protec-
tion, like protection shields, still remains of high importance.
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